top of page

CERTAINTY unveiled at the 6th European CAR T Cell meeting

Jerina Hoxha


CERTAINTY presented at the 6th European CAR T cell meeting in Valencia

The CERTAINTY project participated at the 6th European CAR T cell meeting with its presentation on a cellular immunotherapy virtual twin for personalised cancer treatment. Held on 16 February 2024, within the "Translational II – Focus on European Projects & Networks" session, CERTAINTY unveiled its approach to revolutionising cancer therapy through tailored virtual models.

Hosted by the European Hematology Association and the EBMT, this hybrid event from 15th to 17th February 2024, is the largest of its kind in Europe, attracting experts across the CAR T field including haematologists, oncologists, and patient organisation representatives.

The meeting provided a rich platform for sharing the latest in CAR T science, clinical progress, and innovation, emphasising the fast-evolving nature of the field. For CERTAINTY, it was an opportunity to showcase its pioneering efforts and engage with leading figures in healthcare and research.

bottom of page